A recombinant flu vaccine (Flublok) contains no eggs and was recently approved for use in individuals aged 9 years or older ...

Moderna shared news of the contract termination alongside data from its phase 1/2 trial of mRNA-1018. At baseline, 2.1% of the 300 adults who took part in the trial had hemagglutination inhibition ...

ImmuneOncia Therapeutics, Inc. (CEO Heung-Tae Kim) announced interim results today from the ongoing Phase 1b clinical trial of its next-generation CD47-targeting antibody, IMC-002, in combination with ...

A high-level overview of Liminatus Pharma, Inc. (LIMN) stock. View (LIMN) real-time stock price, chart, news, analysis, analyst reviews and more.

IMC-002 is an IgG4 monoclonal antibody targeting the CD47-SIRPα axis to restore macrophage-mediated phagocytosis of cancer cells. It is a second-generation anti-CD47 antibody designed to minimize ...

According to the interim data, 97.8% of participants achieved hemagglutination inhibition (HAI) antibody titers considered to correlate with protection three weeks after the second dose, a significant ...

Cationic amphiphilic random copolyesters were obtained by copolymerization of 5-Z-amino-δ-valerolactone and ε-caprolactone. The amino content of the final copolymers was controlled by the ...

Seroprevalence of influenza A in Polish cats during the 2023 H5N1 outbreak Viruses 2025, 17, 855 20 June, 2025 Domestic cats have traditionally been overlooked as potential hosts for influenza A ...

Find the latest Liminatus Pharma, Inc. (LIMN) stock quote, history, news and other vital information to help you with your stock trading and investing.

Several studies have shown that experimental measurements of anti-HA antibody immunity (e.g., hemagglutination-inhibition or neutralization assays) can partially explain the evolutionary competition ...